The economics of putting germicidal light in every room, with Misha Gurevich and Vivian Belenky of Aerolamp
Summary
Patrick McKenzie hosts Aerolamp CEO Misha and Chief Scientist Vivian Belenke to discuss far-UVC technology, which uses 222nm light to inactivate airborne pathogens safely. They explain the science behind its safety for human skin and eyes, contrasting it with older, dangerous UV wavelengths. The conversation covers deployment strategies, prioritizing schools and care facilities, and the potential for far-UVC to suppress future pandemics by lowering viral reproduction numbers. Finally, they address current barriers, noting that social adoption and awareness, rather than technical or regulato…
Topics discussed
Introduction to Complex Systems and FAR-UVC
How FAR-UVC inactivates pathogens in the air
Comparison of FAR-UVC efficiency to sunlight
Safety mechanisms: Skin and eye protection
Eye safety studies and pain response
Deployment strategies and fixture types
Cost, accessibility, and social adoption barriers
Prioritizing rollout: Schools and high-risk areas
Installation costs and scaling for institutions
Lamp lifespan and maintenance requirements
Evidence of efficacy: Tuberculosis and senior centers
Potential impact on flu, coronavirus, and pandemics
Marketing challenges and pandemic trauma
Sponsors: Mercury and MongoDB
R0 values and community-wide suppression
Comparison with air filters and ventilation
Multiplicative benefits and diffusion timeline
Manufacturing constraints and cost reduction
Scaling production and price vs. cost dynamics
Home deployment: Cost-benefit analysis
Transmission dynamics and short-range risks
Immune system training and the hygiene hypothesis
Indoor microbiome effects and long-term health
Call to action: Advocacy and social movement
Economic benefits and concluding remarks
Listen ad-free on Castria